Biosynexus Incorporated
Records under this name other than patents Biosynexus Incorporated holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Biosynexus Incorporated
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,146,694 | Fabrication Apparatus for an Assembly of Vanes for an Architectural Covering Formerly held Term ended Term ended Apr 11, 2023 · High confidence | Term ended | Term ended Apr 11, 2023 | High confidence |
| US 7,169,903 | Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria Lapsed on the fee record Ended Jan 30, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jan 30, 2019 | From the USPTO record |
| US 7,166,708 | Process for preparing conjugate vaccines and the conjugate vaccines Term ended Term ended Aug 8, 2018 · From the USPTO record | Term ended | Term ended Aug 8, 2018 | From the USPTO record |
| US 7,777,017 | Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria Term ended Ended no later than Jun 15, 2018 · From the USPTO record | Term ended | Ended no later than Jun 15, 2018 | From the USPTO record |
| US 8,697,639 | Compositions and methods for treating bacteria Formerly held Lapsed on the fee record Ended Apr 15, 2018 · From the USPTO record | Lapsed on the fee record | Ended Apr 15, 2018 | From the USPTO record |
| US 8,568,731 | Staphylococcus aureus antigenic polypeptides and compositions Lapsed on the fee record Ended Oct 29, 2017 · From the USPTO record | Lapsed on the fee record | Ended Oct 29, 2017 | From the USPTO record |
| US 7,585,658 | Staphylococcus aureus antigenic polypeptides and compositions Lapsed on the fee record Ended Sep 8, 2017 · From the USPTO record | Lapsed on the fee record | Ended Sep 8, 2017 | From the USPTO record |
| US 7,576,054 | Compositions and methods for treating bacteria Formerly held Lapsed on the fee record Ended Aug 18, 2017 · From the USPTO record | Lapsed on the fee record | Ended Aug 18, 2017 | From the USPTO record |
| US 7,517,852 | Compositions and methods for treating bacteria Formerly held Lapsed on the fee record Ended Apr 14, 2017 · From the USPTO record | Lapsed on the fee record | Ended Apr 14, 2017 | From the USPTO record |
| US 8,372,958 | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria Lapsed on the fee record Ended Feb 12, 2017 · From the USPTO record | Lapsed on the fee record | Ended Feb 12, 2017 | From the USPTO record |